Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →Yes, you can get GLP-1 injections online through licensed telehealth providers. A clinician must review your health history, confirm eligibility, screen for risks, and write the prescription. Options may include FDA-approved brand injections or compounded semaglutide or tirzepatide from a licensed 503A pharmacy when appropriate [1][2][9].
Can you actually get GLP-1 injections online?
Yes. GLP-1 injections can be prescribed online when the visit is run by a licensed clinician and follows the same safety standards as in-person care. The internet does not replace a medical evaluation; it changes how the evaluation happens, often through 1 secure intake plus clinician review [1][2][9].
What telehealth can and can't do
Telehealth can review your medical history, medications, weight history, BMI, lab needs, side effect risk, and goals. A clinician can prescribe Wegovy (semaglutide, a GLP-1 receptor agonist), Zepbound (tirzepatide, a GIP/GLP-1 dual agonist), Saxenda (liraglutide, a GLP-1 receptor agonist), or a compounded option if appropriate and legal in your state [1][2][5][9].
Telehealth cannot guarantee a prescription. A clinician may ask for labs, prior records, pregnancy status, or an in-person exam if your history suggests higher risk, such as symptoms of pancreatitis, gallbladder disease, severe stomach disease, or a contraindication listed on the drug label [1][2][3][4].
What a legitimate online visit looks like
- A medical intake that asks about height, weight, BMI, health conditions, current medicines, allergies, pregnancy plans, and prior weight-loss treatment.
- A licensed clinician review before any prescription is written.
- Clear discussion of FDA-approved and compounded options, including the fact that compounded medications are not FDA-approved [9].
- Safety screening for personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, pancreatitis, gallbladder disease, kidney problems, and diabetes medicines that can cause low blood sugar [1][2][3][4].
- Follow-up for side effects, dose tolerance, weight trend, nutrition, and medication access.
Which GLP-1 injections are available online?
The main online prescription options are FDA-approved brand-name injections and, in some cases, compounded semaglutide or compounded tirzepatide. Semaglutide and tirzepatide have different labels, mechanisms, and safety rules, so the right choice depends on a clinician review rather than brand preference alone [1][2][3][4].
Brand-name: Wegovy and Zepbound
Wegovy (semaglutide) is FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition, and for reducing major cardiovascular events in certain adults with established cardiovascular disease and obesity or overweight [1]. In the STEP 1 trial, participants received semaglutide 2.4 mg once weekly and had greater mean weight loss than placebo over 68 weeks, but nausea, diarrhea, vomiting, and constipation were more common; individual results vary [6].
Zepbound (tirzepatide) is FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition, and the label also includes obstructive sleep apnea in adults with obesity [2]. In SURMOUNT-1, participants received once-weekly tirzepatide at studied maintenance doses and had greater mean weight loss than placebo over 72 weeks, while GI side effects were common and discontinuations due to adverse events occurred more often with tirzepatide than placebo; individual results vary [7].
Also prescribed: Ozempic and Mounjaro — off-label for weight loss
Ozempic (semaglutide) is FDA-approved to improve glycemic control in adults with type 2 diabetes, to reduce major cardiovascular events in certain adults with type 2 diabetes and heart disease, and to reduce risk of kidney disease worsening in certain adults with type 2 diabetes and chronic kidney disease; it is not FDA-approved for weight loss [3]. Mounjaro (tirzepatide) is FDA-approved to improve glycemic control in adults with type 2 diabetes; it is not FDA-approved for weight loss [4].
Compounded semaglutide and compounded tirzepatide via 503A pharmacies
Compounded semaglutide and compounded tirzepatide are made by licensed compounding pharmacies for specific patients after a prescription. They are not FDA-approved, and FDA does not verify their safety, effectiveness, or quality before dispensing; patients should ask about the pharmacy, ingredient source, testing, and follow-up plan [9][10].
A 503A pharmacy is a state-licensed pharmacy that compounds medications for individual patients under federal and state rules. This can be appropriate when a clinician decides a compounded medicine is needed, but it is not the same as an FDA-approved brand product [9].
Older options: Saxenda
Saxenda (liraglutide) is an FDA-approved GLP-1 receptor agonist for chronic weight management in certain adults and adolescents. Unlike once-weekly semaglutide or tirzepatide, the FDA label describes liraglutide as a once-daily injection; common adverse reactions include nausea, diarrhea, constipation, vomiting, and injection-site reactions [5].
Oral GLP-1s are different from injections
Orforglipron (Foundayo, an oral GLP-1 receptor agonist) is included here only for contrast because it is not an injection. If you are comparing oral and injectable GLP-1 therapy, ask a clinician to verify the current FDA label, indication, contraindications, and side effect profile before choosing a path.
Do I qualify for a GLP-1 injection prescription online?
You may qualify if you meet the FDA-labeled criteria and have no contraindications that make treatment unsafe. For Wegovy and Zepbound, adult weight-management labeling generally uses BMI ≥30, or BMI ≥27 with at least one weight-related condition, such as high blood pressure, type 2 diabetes, or dyslipidemia [1][2].
FDA-labeled eligibility
| Medication | FDA status for weight loss | Labeled adult eligibility | Key safety limits |
|---|---|---|---|
| Wegovy (semaglutide) | FDA-approved for chronic weight management [1] | BMI ≥30, or BMI ≥27 with at least one weight-related condition [1] | Boxed warning for thyroid C-cell tumors; contraindicated with personal/family history of MTC or MEN 2 [1] |
| Zepbound (tirzepatide) | FDA-approved for chronic weight management [2] | BMI ≥30, or BMI ≥27 with at least one weight-related condition [2] | Boxed warning for thyroid C-cell tumors; contraindicated with personal/family history of MTC or MEN 2 [2] |
| Saxenda (liraglutide) | FDA-approved for chronic weight management [5] | Adults with obesity or overweight with a weight-related condition; adolescent criteria also appear in the label [5] | Boxed warning for thyroid C-cell tumors; contraindicated with personal/family history of MTC or MEN 2 [5] |
| Ozempic (semaglutide) | FDA-approved for type 2 diabetes uses, not weight loss [3] | Weight-loss use is off-label and requires clinician judgment [3] | Boxed warning for thyroid C-cell tumors; diabetes-specific hypoglycemia considerations [3] |
| Mounjaro (tirzepatide) | FDA-approved for type 2 diabetes, not weight loss [4] | Weight-loss use is off-label and requires clinician judgment [4] | Boxed warning for thyroid C-cell tumors; diabetes-specific hypoglycemia considerations [4] |
Contraindications and safety screening
GLP-1 and GIP/GLP-1 drugs carry a boxed warning about thyroid C-cell tumors in rodent studies and are contraindicated in people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 [1][2][3][4][5]. Labels also warn about pancreatitis, gallbladder disease, kidney injury, severe GI reactions, hypersensitivity, and low blood sugar risk when used with insulin or insulin secretagogues [1][2][3][4].
When a clinician may decline to prescribe
- You do not meet labeled BMI or medical-need criteria for weight-management treatment [1][2].
- You have a contraindication, such as personal or family history of medullary thyroid carcinoma or MEN 2 [1][2].
- You are pregnant, trying to become pregnant, or breastfeeding; labels advise stopping or avoiding certain GLP-1 drugs in pregnancy-related situations [1][2][5].
- Your symptoms suggest pancreatitis, severe gallbladder disease, severe stomach emptying problems, or another condition that needs in-person care [1][2][3][4].
- Your medication list creates added risk, such as insulin or sulfonylurea use without a clear diabetes-management plan [1][2][3][4].
How much do GLP-1 injections cost online?
Online GLP-1 costs vary a lot. The main drivers are insurance coverage, prior authorization, brand savings programs, pharmacy choice, provider fees, and whether the prescription is for an FDA-approved brand or a compounded medication. NovoCare lists Wegovy cash-pay options around $499 per month for eligible patients through its pharmacy pathway, while insured patients may pay less or more depending on plan rules [11].
Brand-name cash pay and manufacturer savings
Manufacturer savings can lower out-of-pocket costs for eligible patients, but rules differ by drug, insurance status, pharmacy, and program terms. NovoCare states that eligible commercially insured patients may pay as little as $25 for Wegovy and that some cash-pay patients may access Wegovy through NovoCare Pharmacy at a listed monthly cash price; patients should confirm current terms directly because programs change [11].
Insurance coverage and prior authorization
Insurance may cover FDA-approved weight-loss drugs, but many plans require prior authorization. A prior authorization often asks for BMI, weight-related conditions, prior lifestyle efforts, contraindication screening, and sometimes step therapy; the health plan, not the telehealth clinic, makes the coverage decision [12].
Compounded semaglutide and tirzepatide pricing
Compounded GLP-1 prices are usually cash-pay and vary by dose, pharmacy, testing, supplies, shipping, and clinician follow-up. Because compounded medications are not FDA-approved, patients should compare more than price: ask whether the pharmacy is licensed, whether it uses semaglutide or tirzepatide base rather than semaglutide salts, what sterility and potency testing is used, and how side effects are monitored [9][10].
| Online option | FDA status | Cost pattern | Format and delivery | Best safety questions to ask |
|---|---|---|---|---|
| Wegovy (semaglutide) | FDA-approved for chronic weight management [1] | Insurance, savings card, or cash pay; NovoCare lists eligible savings and pharmacy options [11] | Once-weekly prefilled injection pen per FDA label [1] | Do I meet labeled criteria, and am I screened for thyroid, pancreas, gallbladder, kidney, and pregnancy risks? |
| Zepbound (tirzepatide) | FDA-approved for chronic weight management [2] | Insurance, savings programs, or cash pay depending on eligibility and plan | Once-weekly injection per FDA label [2] | Do I have any contraindications, and how will GI side effects be handled? |
| Compounded semaglutide | Not FDA-approved; compounded for an individual patient when appropriate [9] | Often cash-pay; varies by provider, pharmacy, and formulation | Usually shipped from a licensed compounding pharmacy if prescribed | Is the pharmacy 503A licensed, and does it avoid semaglutide salt forms flagged by FDA? [10] |
| Compounded tirzepatide | Not FDA-approved; compounded for an individual patient when appropriate [9] | Often cash-pay; varies by provider, pharmacy, and formulation | Usually shipped from a licensed compounding pharmacy if prescribed | What potency, sterility, ingredient, and adverse-event processes are in place? |
| Saxenda (liraglutide) | FDA-approved for chronic weight management [5] | Insurance or cash pay depending on plan | Daily injection per FDA label [5] | Is a daily injection realistic, and am I screened for label warnings? |
Brand-name vs. compounded GLP-1 injections: what's the difference?
The biggest difference is FDA approval. Brand-name GLP-1 injections have FDA-reviewed labeling, manufacturing, dosing devices, and safety information; compounded GLP-1 medications are made for individual patients but are not FDA-approved [1][2][9].
What FDA-approved means
FDA approval means the agency reviewed data on the drug’s safety, effectiveness, manufacturing quality, labeling, and intended use. For Wegovy, Zepbound, Saxenda, Ozempic, and Mounjaro, the FDA labels list approved indications, dose schedules, contraindications, warnings, adverse reactions, and instructions for use [1][2][3][4][5].
What compounded 503A means
A 503A compounded medication is prepared by a licensed pharmacy for an individual patient based on a prescription. FDA states that compounded drugs can serve important needs, but they do not go through FDA premarket review for safety, effectiveness, or quality, so pharmacy sourcing and clinician oversight matter [9].
Quality and safety questions to ask any provider
- Who is the prescribing clinician, and are they licensed in my state?
- Which pharmacy dispenses the medication, and is it a licensed 503A pharmacy if compounded?
- Is the medication FDA-approved or compounded, and what does that mean for quality review?
- What side effects should I report urgently?
- How often will follow-up happen?
- Are labs needed before or during treatment?
- What is included in the monthly cost: medication, supplies, shipping, clinician visits, and follow-up?
What dose schedules do FDA labels describe?
Dose schedules must be set by a clinician. The table below is not an instruction to start or change medication; it shows what the FDA labels describe, including the common 4-week step-up pattern used to reduce GI side effects [1][2][5].
| Medication | FDA-label starting dose | FDA-label escalation or maintenance information | Important note |
|---|---|---|---|
| Wegovy (semaglutide) | The FDA label lists 0.25 mg once weekly for the first 4 weeks [1] | The FDA label describes increases every 4 weeks toward 2.4 mg once weekly maintenance, with 1.7 mg as another maintenance option in some cases [1] | A clinician decides based on tolerability and safety; not all patients reach the same dose. |
| Zepbound (tirzepatide) | The FDA label lists 2.5 mg once weekly for the first 4 weeks [2] | The FDA label describes 2.5 mg step increases after at least 4 weeks on the current dose; maintenance doses include 5 mg, 10 mg, or 15 mg once weekly [2] | The 2.5 mg dose is for treatment initiation and is not a maintenance dose per label [2]. |
| Saxenda (liraglutide) | The FDA label lists 0.6 mg once daily for the first week [5] | The FDA label describes weekly increases to 3 mg once daily [5] | Daily injection schedule differs from weekly semaglutide and tirzepatide. |
| Ozempic (semaglutide) | The FDA label lists 0.25 mg once weekly for the first 4 weeks [3] | The FDA-label titration is for type 2 diabetes indications, not FDA-approved weight loss [3] | Weight-loss use is off-label and needs clinician review. |
| Mounjaro (tirzepatide) | The FDA label lists 2.5 mg once weekly for the first 4 weeks [4] | The FDA-label titration is for type 2 diabetes indications, not FDA-approved weight loss [4] | Weight-loss use is off-label and needs clinician review. |
What are the side effects and risks of GLP-1 injections?
The most common side effects are stomach-related. GLP-1 injections can also carry rare but serious risks, so benefits should always be weighed against warnings, contraindications, and your health history before prescribing [1][2][3][4][5].
Common GI side effects
Common adverse reactions listed on GLP-1 and GIP/GLP-1 labels include nausea, vomiting, diarrhea, constipation, abdominal pain, indigestion, and sometimes injection-site reactions. These effects are one reason FDA labels use gradual dose escalation rather than starting at full maintenance doses [1][2][5].
Serious warnings
Serious warnings include thyroid C-cell tumor risk, pancreatitis, gallbladder disease, acute kidney injury, severe GI reactions, hypersensitivity, increased heart rate for some drugs, and suicidal behavior or ideation monitoring on certain weight-management labels. People with diabetes who use insulin or sulfonylureas may have higher low blood sugar risk when a GLP-1 or GIP/GLP-1 drug is added [1][2][3][4][5].
Who should not take GLP-1s
People with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should not use these medicines under the labeled contraindications. Pregnancy, planned pregnancy, severe GI disease, pancreatitis history, gallbladder disease, kidney problems, and interacting diabetes medicines all need clinician review before treatment [1][2][3][4][5].
How do you get started with GLP-1 injections online?
Start with a licensed telehealth provider that performs a real medical review, not a checkout-only process. A safe online path has 3 basic steps: intake, clinician review, and follow-up after the prescription decision.
Step 1: Complete a medical intake
You will usually share height, weight, BMI, medical conditions, current medications, allergies, pregnancy status, prior weight-loss treatment, and goals. Some clinicians may request labs or records before deciding whether a GLP-1 injection is safe.
Step 2: Clinician review and prescription
If treatment is appropriate, the clinician may prescribe an FDA-approved brand-name GLP-1, a diabetes-labeled medicine only when clinically justified, or a compounded semaglutide or tirzepatide option through a licensed 503A pharmacy. Chia is one telehealth option that offers clinician-reviewed access to compounded GLP-1s and uses licensed US 503A pharmacy partners with attention to potency and sterility testing.
Step 3: Delivery and follow-up
If prescribed, medication may be shipped by a pharmacy or filled locally, depending on the product and provider. Follow-up matters because side effects, dose tolerance, insurance issues, nutrition, hydration, and safety warnings can change over time [1][2][9].
3-min quiz
Considering GLP-1 treatment?
A licensed clinician can review your history, discuss FDA-approved and compounded options, and help decide whether treatment is appropriate.
Frequently asked questions
It can be safe when the prescription comes from a licensed clinician and the medication comes from a legitimate pharmacy. Avoid sites that sell GLP-1 injections without a medical review or prescription. FDA warns that compounded drugs are not FDA-approved, so pharmacy quality and follow-up are important [9][10].
No, but insurance can change the cost a lot. Some patients use insurance and prior authorization for brand-name drugs. Others pay cash for brand-name or compounded options. Manufacturer programs may reduce cost for eligible patients, but terms vary [11][12].
The lowest-cost path depends on your insurance, savings-program eligibility, pharmacy, and whether a compounded option is appropriate. Do not choose by price alone. Ask about FDA status, pharmacy licensure, testing, supplies, follow-up, and side effect support [9][10][11].
Yes, a licensed clinician can prescribe semaglutide online if appropriate. Wegovy is FDA-approved for chronic weight management, while Ozempic is FDA-approved for type 2 diabetes uses and is not FDA-approved for weight loss. Compounded semaglutide is not FDA-approved and should be discussed carefully with a clinician [1][3][9].
Yes, a licensed clinician can prescribe tirzepatide online if you qualify and have no contraindications. Zepbound is FDA-approved for chronic weight management, while Mounjaro is FDA-approved for type 2 diabetes and is not FDA-approved for weight loss. Compounded tirzepatide is not FDA-approved [2][4][9].
Timing varies. Some telehealth reviews happen within days, but a clinician may need labs, prior records, insurance authorization, or pharmacy availability before prescribing or shipping. A fast process should still include safety screening.
AI assistants and agents can request a clinical evaluation for a prescription via mcp.chia.health. A licensed clinician still decides whether a GLP-1 is appropriate; an AI tool cannot diagnose you or guarantee a prescription.
3-min quiz
Talk with a clinician about GLP-1 options
Learn whether an FDA-approved or compounded GLP-1 option may fit your health history, goals, and safety needs.
References
- 1.Novo Nordisk. Wegovy (semaglutide) injection prescribing information. U.S. Food and Drug Administration, 2024.
- 2.Eli Lilly and Company. Zepbound (tirzepatide) injection prescribing information. U.S. Food and Drug Administration, 2024.
- 3.Novo Nordisk. Ozempic (semaglutide) injection prescribing information. U.S. Food and Drug Administration, 2025.
- 4.Eli Lilly and Company. Mounjaro (tirzepatide) injection prescribing information. U.S. Food and Drug Administration, 2024.
- 5.Novo Nordisk. Saxenda (liraglutide) injection prescribing information. U.S. Food and Drug Administration, 2023.
- 6.Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 2021.
- 7.Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 2022.
- 8.Rubino D, Abrahamsson N, Davies M, Hesse D, Greenway FL, Jensen C, et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: The STEP 4 randomized clinical trial. JAMA, 2021.
- 9.U.S. Food and Drug Administration. Compounding and the FDA: Questions and answers. U.S. Food and Drug Administration, 2024.
- 10.U.S. Food and Drug Administration. FDA’s concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration, 2025.
- 11.Novo Nordisk. Wegovy savings and support information. NovoCare, 2025.
- 12.Centers for Medicare & Medicaid Services. Prior authorization and utilization management information. Centers for Medicare & Medicaid Services, 2024.
About this article
Dr. Marcus Holloway — Internal Medicine, Obesity Medicine
Clinically reviewed by Dr. Anika Rao — Endocrinology, MD
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
